Details of the Drug Reposition

General Information of This Drug (ID: DMCKL5V)

Drug Name
Efalizumab   DMCKL5V
Synonyms Raptiva; Raptiva (TN); Efalizumab (USAN/INN)
Therapeutic Class
Immunomodulatory Agents
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Psoriasis vulgaris DIS6M7AN EA90 Approved [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Renal transplantation DISVLUUA NE84 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6593).